Find a Provider | Print Page | Contact Us | Report Abuse | Sign In | Register
Corporate Council Members
Share |

Corporate Council Members Support and Advance AIPM's Mission

The Academy of Integrative Pain Management greatly values its relationships with the commercial sponsors who make the products that enable members to provide the best pain care possible. These sponsors support the goals and mission of AIPM and its programs through a variety of means, including joining the AIPM’s Corporate Council Program.

Many benefits of Corporate Council participation are the same across all levels, while others increase in value as the level of corporate support increases. AIPM welcomes all commercial supporters. Learn more about joining this program here.


Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and



Depomed, Inc. is a leading specialty pharmaceutical company focused on developing and commercializing products for pain and neurology-related disorders. Founded in 1995, Depomed has built a strong market presence with a highly differentiated portfolio of six marketed products in the areas of mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain.



At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.


Purdue Pharma, LP

Purdue Pharma L.P., a privately held pharmaceutical company founded by physicians, is known for its pioneering research on persistent pain. Focused on the needs of patients, the company is dedicated to finding, developing, and bringing to market new medicines and related products that promote health and healing. To raise awareness of the importance of pain management, Purdue sponsors Partners Against Pain. This alliance of patients, caregivers, and healthcare providers seeks to alleviate unnecessary suffering by advancing standards of pain care through education and advocacy.


Teva North America

Teva Pharmaceutical Industries Ltd. is the largest maker of generic pharmaceutical products, has a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. The branded businesses focus on CNS, oncology, pain, respiratory, women’s health and biologics.



KemPharm is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that are designed to be improved versions of widely prescribed, approved drugs. We employ our Ligand Activated Therapy (LAT) platform technology to create new molecular entity (NME) prodrugs in order to improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety. KemPharm has employed its LAT prodrug platform to create a diverse pipeline of prodrug therapeutics that target large market opportunities in pain, attention deficit hyperactivity disorder (ADHD) and other central nervous system indications.


Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management. The Company promotes its branded products to physicians through its two sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.



Endo Pharmaceuticals is a therapeutically focused pharmaceutical company specializing in the discovery, development and manufacture of quality pain management and supportive care products. Endo is committed to advancing pain management and supportive care treatment through strong research and development programs, innovative technology and delivery systems, collaborative medical education initiatives and community awareness projects.


Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. The Company is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, thrombotic disorders, stroke risk reduction, opioid-induced constipation, IV iron therapy and metastatic melanoma.